Abstract:Broadly neutralizing antibodies (bnAbs) that neutralize diverse variants of a particular virus are of considerable therapeutic interest 1 . Recent advances have enabled us to isolate and engineer these antibodies as therapeutics, but eliciting them through vaccination remains challenging, in part due to our limited understanding of how antibodies evolve breadth 2 . Here, we analyze the landscape by which an anti-influenza receptor binding site (RBS) bnAb, CH65, evolved broad affinity to diverse H1 influenza strains 3,4 . We do this by generating an antibody library of all possible evolutionary intermediates between the unmutated common ancestor (UCA) and the affinity-matured CH65 antibody and measure the affinity of each intermediate to three distinct H1 antigens. We find that affinity to each antigen requires a specific set of mutations - distributed across the variable light and heavy chains - that interact non-additively ( i.e. , epistatically). These sets of mutations form a hierarchical pattern across the antigens, with increasingly divergent antigens requiring additional epistatic mutations beyond those required to bind less divergent antigens. We investigate the underlying biochemical and structural basis for these hierarchical sets of epistatic mutations and find that epistasis between heavy chain mutations and a mutation in the light chain at the V H -V L interface is essential for binding a divergent H1. Collectively, this work is the first to comprehensively characterize epistasis between heavy and light chain mutations and shows that such interactions are both strong and widespread. Together with our previous study analyzing a different class of anti-influenza antibodies 5 , our results implicate epistasis as a general feature of antibody sequence-affinity landscapes that can potentiate and constrain the evolution of breadth.

Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation

Key Mutations Stabilize Antigen-Binding Conformation During Affinity Maturation of A Broadly Neutralizing Influenza Antibody Lineage

Affinity Maturation In An Hiv Broadly Neutralizing B-Cell Lineage Through Reorientation Of Variable Domains

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors

Sequence Intrinsic Somatic Mutation Mechanisms Contribute to Affinity Maturation of Vrc01-Class Hiv-1 Broadly Neutralizing Antibodies

Diversity against adversity: How adaptive immunity evolves potent antibodies

Learning the heterogeneous hypermutation landscape of immunoglobulins from high-throughput repertoire data

Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody

Convergent Evolution in Breadth of Two VH6-1-Encoded Influenza Antibody Clonotypes from a Single Donor.

Immunogenic Stimulus for Germline Precursors of Antibodies That Engage the Influenza Hemagglutinin Receptor-Binding Site.

Related Mechanisms Of Antibody Somatic Hypermutation And Class Switch Recombination

Affinity Maturation of B Cells Involves Not Only a Few but a Whole Spectrum of Relevant Mutations.

Understanding Memory B Cell Selection

Mutability and hypermutation antagonize immunoglobulin codon optimality

Transducing the Affinity of Antigen Recognition into Graded Structural Modifications of the Antibody Product (43.21)

Survival probability and size of lineages in antibody affinity maturation

Immunoglobulin somatic hypermutation in a defined biochemical system recapitulates affinity maturation and permits antibody optimization

Memory in the B–cell compartment: antibody affinity maturation

Antigen affinity and site of immunization dictate B cell recall responses

Using B cell receptor lineage structures to predict affinity